Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT03000543

Completed

Novel Isotope Dilution Technique to Assess Vitamin A Status

Healthy Infants | Infants With an Inflammatory Condition
NCT02866942

Completed

Safety of Nasal Influenza Immunisation in Children With Asthma (SNIFFLE-4)

Asthma
NCT03420053

Completed

Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults

Malaria | Malaria,Falciparum
NCT01073293

Completed

A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)

Papillomavirus Infections
NCT02988739

Completed

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

Influenza in Human
NCT01170078

Completed

A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment

Chronic Renal Failure
NCT00518726

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects

Influenza
NCT00743275

Completed

A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Influenza
NCT01356823

Completed

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Cervical Cancer | Cervical Intraepithelial Neoplasia
NCT01765413

Completed

Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines

Healthy
NCT01603875

Completed

Immune Response in Adults to PrEP and Simulated Booster PEP With a New CPRV

Efficacy of the New CPRV
NCT00107159

Completed

Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma

Melanoma (Skin)
NCT01278433

Completed

A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China

Poliomyelitis | Polio
NCT01508247

Completed

A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months

Hand, Foot and Mouth Disease | Herpangina | Other EV71-associated Diseases
NCT00003556

Completed

Vaccine Therapy in Treating Patients With Melanoma

Melanoma (Skin)
NCT00455221

Completed

Safety Assessment of a Multipeptide-gene Vaccine in CML

Leukemia, Myeloid, Chronic
NCT01069601

Terminated

H1N1sw Vaccine in Adult Transplant Recipients

Immunocompromised
NCT00928902

Completed

Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma (MEL36)

Melanoma
NCT01181336

Completed

Phase 1b Influenza Vaccine Study in Healthy Subjects

Influenza
NCT00900991

Completed

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children

Influenza
NCT00431808

Unknown

Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])

Malaria
NCT05305183

Not yet recruiting

A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis

Osteoporosis
NCT03071575

Completed

Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age

Measles | Rubella | Rubella Syndrome, Congenital
NCT04535037

Completed

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

Diphtheria
NCT04714229

Completed

Safety and Immunogenicity of Meningococcal Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years Old

Infection, Meningococcal
NCT04632537

Withdrawn

BCG Vaccination to Prevent COVID-19 (NUEVA)

COVID-19
NCT01702428

Completed

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

Measles | Rubella | Mumps
NCT00775138

Completed

Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.

Bronchiectasis
NCT00614614

Completed

Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014

Infections, Meningococcal
NCT01248884

Completed

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b
NCT00307034

Completed

Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule

Infections, Streptococcal
NCT00440531

Completed

Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)

Hepatitis B
NCT02420444

Completed

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (C-013-404)

Tuberculosis
NCT01277705

Completed

Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®

Tetanus | Diphtheria | Acellular Pertussis
NCT00092391

Completed

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

Measles | Rubella | Mumps | Varicella
NCT01266707

Unknown

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT00810914

Unknown

Patient Controlled Epidural Analgesia Versus Continuous Epidural Infusion: Obstetrical and Neonatal Outcomes (Epidural)

Pain
NCT00262002

Completed

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants

Prevention of Meningococcal Disease
NCT04762680

Completed

Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older (VAT00002)

COVID-19
NCT02545777

Unknown

The Clinical Study on Treating Acute Gouty Arthritis Using Both Internal and External Therapy of Tonifying Spleen and Descending Turbid

Acute Gouty Arthritis
NCT05084989

Completed

Safety, and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) (ReCOV)

COVID-19
NCT00694551

Completed

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Prostate Cancer
NCT00310856

Completed

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

Meningococcal Meningitis
NCT02275039

Completed

p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian Epithelial Cancer
NCT02811484

Withdrawn

Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes (Dexlar)

Diabetes Mellitus, Type 2
NCT01676844

Unknown

Investigating a New Way of Giving Medicine to Newborn and Preterm Babies

Osteopenia of Prematurity | Hypophosphataemia
NCT01080235

Completed

Improving Quality of Care for Elderly Patients in the Educational Setting (MacyCoVE)

Elderly
NCT03055338

Completed

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

Schizophrenia, Acute Episode
NCT05279456

Completed

A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

COVID-19
NCT02094833

Completed

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b Infection

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations